265
Views
17
CrossRef citations to date
0
Altmetric
Reviews

Emerging drugs for small-cell lung cancer

, MD & , MD
Pages 591-606 | Published online: 20 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Giulio Metro, Simona Duranti, Matthias Joachim Fischer, Federico Cappuzzo & Lucio Crinò. (2012) Emerging drugs for small cell lung cancer – an update. Expert Opinion on Emerging Drugs 17:1, pages 31-36.
Read now

Articles from other publishers (16)

Yanli Li, Xiaomin Liu & Zhongliang Ma. 2022. Precision Medicine. Precision Medicine 189 218 .
Jin Wang, Shuai Tan, Ping-ping Yan, Xue Xiao, Hao Zhang, San-qi Zhang, Wei Li, Yong-xiao Cao & Hong-ying Wang. (2020) Irreversible epidermal growth factor receptor inhibitor Z25h exhibits pronounced inhibition on non-small cell lung adenocarcinoma cell line Hcc827. Anti-Cancer Drugs 32:4, pages 417-426.
Crossref
Sarah Sharman Moser, Jair Bar, Inna Kan, Keren Ofek, Raanan Cohen, Nikhil Khandelwal, Varda Shalev, Gabriel Chodick & Nava Siegelmann-Danieli. (2021) Real World Analysis of Small Cell Lung Cancer Patients: Prognostic Factors and Treatment Outcomes. Current Oncology 28:1, pages 317-331.
Crossref
Xiaomin Liu, Ping Wang, Caiyan Zhang & Zhongliang Ma. (2017) Epidermal growth factor receptor (EGFR): A rising star in the era of precision medicine of lung cancer. Oncotarget 8:30, pages 50209-50220.
Crossref
Barbara A. Helfrich, Jihye Kim, Dexiang Gao, Daniel C. Chan, Zhiyong Zhang, Aik-Choon Tan & Paul A. BunnJrJr. (2016) Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo . Molecular Cancer Therapeutics 15:10, pages 2314-2322.
Crossref
Xu Wang, Kewei Ma, Yizhuo Wang, Hua He, Ji-fan Hu & Wei Li. (2016) Evaluation of Circulating Tumor Cells in Predicting Therapeutic Response in Small Cell Lung Cancer Patients. Archives of Medical Research 47:6, pages 454-459.
Crossref
Giulio Metro, Biagio Ricciuti, Rita Chiari, Marina Baretti, Lorenzo Falcinelli, Diana Giannarelli, Angelo Sidoni, Giannis Mountzios, Lucio Crinò, Guido Bellezza, Alberto Rebonato, Piero Ferolla & Luca Toschi. (2016) Survival outcomes and incidence of brain recurrence in high-grade neuroendocrine carcinomas of the lung: Implications for clinical practice. Lung Cancer 95, pages 82-87.
Crossref
Arjan Gower, Yisong Wang & Giuseppe Giaccone. (2014) Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer. Journal of Molecular Medicine 92:7, pages 697-707.
Crossref
Demetrios Simos, Golmehr Sajjady, Melissa Sergi, Mun Sem Liew, Raffaele Califano, Cheryl Ho, Natasha Leighl, Shane White, Yvonne Summers, William Petrcich & Paul Wheatley-Price. (2014) Third-Line Chemotherapy in Small-Cell Lung Cancer: An International Analysis. Clinical Lung Cancer 15:2, pages 110-118.
Crossref
Matthew Whitehurst & Alberto Chiappori. (2013) Immunotherapy treatments for small-cell lung cancer: past, present and future. Lung Cancer Management 2:6, pages 517-525.
Crossref
David R. Spigel & Mark A. Socinski. (2013) Rationale for Chemotherapy, Immunotherapy, and Checkpoint Blockade in SCLC: Beyond Traditional Treatment Approaches. Journal of Thoracic Oncology 8:5, pages 587-598.
Crossref
Michael J. Kelley, Jeffrey A. Bogart, Lydia. D. Hodgson, Rafat H. Ansari, James N. Atkins, Herbert Pang, Mark R. Green & Everett E. Vokes. (2013) Phase II Study of Induction Cisplatin and Irinotecan Followed by Concurrent Carboplatin, Etoposide, and Thoracic Radiotherapy for Limited-Stage Small-Cell Lung Cancer, CALGB 30206. Journal of Thoracic Oncology 8:1, pages 102-108.
Crossref
Mirko Lekic, Viljem Kovac, Nadja Triller, Lea Knez, Aleksander Sadikov & Tanja Cufer. (2012) Outcome of small cell lung cancer (SCLC) patients with brain metastases in a routine clinical setting. Radiology and Oncology 46:1.
Crossref
. (2011) Current World Literature. Current Opinion in Oncology 23:2, pages 227-234.
Crossref
Shadi Haddadin & Michael C. Perry. (2011) History of Small-Cell Lung Cancer. Clinical Lung Cancer 12:2, pages 87-93.
Crossref
Christine GalustianVictoria SungBlake BartlettLindsey RolfeAngus Dalgleish. (2010) Recent Pharmacological Advances: Focus on Small-cell Lung Cancer. Clinical Medicine Insights: Therapeutics 2, pages CMT.S44.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.